Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

NEW YORK and HILDEN, Germany – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  predictive or prognostic tools for  use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in cancer treatment. This will [...]

QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play key roles in [...]

New Spectronaut™ Pulsar from Biognosys enables spectral library free DIA

Zurich-Schlieren (CH) – Biognosys AG, a leading proteomics company, announced today the release of its new toolbox for easy data-independent acquisition, DIA. The toolbox consists of the new directDIA™ workflow and Spectronaut™ Pulsar analysis software – enabling researchers with a DIA-performance workflow, without having to generate a spectral library. DIA is the most sophisticated discovery [...]

Tecan appoints Erik Norström Head of Corporate Development

Männedorf, Switzerland - The Tecan Group (SIX Swiss Exchange: TECN) announced today that Erik Norström has been appointed Head of Corporate Development and a member of the Management Board. He will assume his new position at Tecan no later than December 1, 2017. Erik Norström held a number of Corporate Development and M&A positions with increasing [...]

Pressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split

Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on Monday, June 5, 2017 SOUTH EASTON, MA ---- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company's outstanding convertible securities will [...]

Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.--Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint [...]

Streck signs distribution agreement with Nordic BioSite

Omaha, NE – Streck, Inc. and Nordic BioSite, a life sciences products distributor in Sweden, Finland, Denmark and Norway, have signed a distribution agreement for Streck’s full portfolio of cell stabilization, molecular and core products. Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; [...]

Sheldon Manufacturing Releases Redesigned 2017 BACTRON Anaerobic Chamber

CORNELIUS, OR:  Sheldon Manufacturing Inc. is pleased to announce the release of their 2017 BACTRON anaerobic chamber family. BACTRON chambers are total anaerobic process workstations. Samples can be prepared, cultured, and inspected in the oxygen-free chamber and standard incubator. BACTRON chambers now include an integrated vacuum pump for quieter operation. The biggest airlock on the [...]

Leading German University opts for second Syngene imaging system

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, today announced its G:BOX Chemi XX6 multi-application imager is being utilised by scientists at a top University in Germany to speed up analysis of genes and proteins associated with neurodegenerative conditions. Researchers at the German University are using a G:BOX Chemi XX6 multi-application imager to [...]

Simulations Plus Closes Acquisition of DILIsym Services, Inc.

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Stock Purchase Agreement (the “Agreement”) with DILIsym Services, Inc. (“DILIsym”) of Research Triangle Park, North Carolina, announced on May 1, 2017, has been closed as of today, and DILIsym is now a division [...]

Access IBO on Knowledge Center